deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01753765

Study Evaluating the Treatment of Occipital Neuralgia

A Prospective Non-Randomized Unblinded Study Evaluating the Treatment of Occipital Neuralgia With the Cryo-Touch III Device

Sponsor: Pacira Pharmaceuticals, Inc

Updated 9 times since 2017 Last updated: Jan 22, 2024 Started: Oct 31, 2012 Primary completion: Dec 31, 2013 Completion: Jul 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Occipital Neuralgia, this trial is completed. The trial is conducted by Pacira Pharmaceuticals, Inc and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Dec 2019 · 18 months · monthly snapshotCompleted~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2023 · 30 months · monthly snapshotCompleted~Jul 2023 – ~Feb 2024 · 7 months · monthly snapshotCompleted~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Feb 2024 — Jul 2024 [monthly]

    Completed NA

  4. Jul 2023 — Feb 2024 [monthly]

    Completed NA

  5. Jan 2021 — Jul 2023 [monthly]

    Completed NA

Show 4 earlier versions
  1. Dec 2019 — Jan 2021 [monthly]

    Completed NA

  2. Jun 2018 — Dec 2019 [monthly]

    Completed NA

  3. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  4. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pacira Pharmaceuticals, Inc
Data source: Pacira Pharmaceuticals, Inc

For direct contact, visit the study record on ClinicalTrials.gov .